Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer

Completed · Not applicable · Has a placebo group

Conditions studied: Breast Cancer

In brief

RATIONALE: High estrogen levels may be associated with dense breast tissue and an increased risk of developing breast cancer. Exemestane may be effective in preventing the development of breast cancer by decreasing estrogen levels and reducing breast density. PURPOSE: Randomized clinical trial to study the effectiveness of exemestane in preventing the development of breast cancer by decreasing estrogen levels and reducing breast density in postmenopausal women who are at increased risk for breast cancer.

Key facts

Study ID
NCT00066586
Run by
NCIC Clinical Trials Group
People needed
98
Starts
2001-08-01
Expected to finish
2009-02-10
Last updated by the study team
2020-04-02

Who can join

Age: any, up to 120. Sex: female. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.